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Abstract Introduction Long-term employment rates have
been studied in cancer survivors, but little is known about
the return to work of cancer patients. This study investi-
gated return to work (RTW) within 2 years after the diag-
nosis of different types of cancer. Methods This prospective
study investigated the associations of demographics (age,
gender, socioeconomic status, and residential region) and
occupational factors (occupation, duration of employment,
and company size) of employees absent from work due to
cancer with the time to partial RTW, deﬁned as working at
least 50% of the earnings before sickness absence. Like-
wise, the associations of demographics and occupational
factors with full RTW at equal earnings as before sickness
absence were investigated. Results The cohort included
5,234 employees who had been absent from work due to
cancer between January 2004 and December 2006. The
time to partial RTW was shortest among employees with
skin cancer (median 55 days) and longestamong employees
with lung cancer (median 377 days). There were no sig-
niﬁcant associations between RTW and demographics.
With regard to the occupational factors, employees in high
occupational classes started working earlier than those in
low occupational classes, but the time to full RTW did not
differ signiﬁcantly across occupational classes. Employees
working in large companies returned to work earlier than
those working in small companies. Conclusion RTW after
different types of cancer depended on occupational factors
rather than demographics.
Keywords Cancer   Sick leave   Return to work  
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Introduction
In The Netherlands, more than 33,000 gainfully employed
men and women were newly diagnosed with cancer in
2006. Recent improvements in screening and treatment
have not only increased cancer survivorship [1], but also
the ability of employees to resume their work after cancer
[2–4]. Return to work after cancer can be regarded as social
recovery and adds to the survivors’ quality of life.
Recent studies on the employment of cancer survivors
have focused on employment rates three to 20 years after
diagnosis based on national employment statistics [2, 5].
Overall, cancer survivors were 1.4 times more likely to be
unemployed on the long-term than healthy controls [6].
Three years after diagnosis, the employment rate of Finnish
cancer survivors was 71% (range 41–84%) and varied
considerably per cancer type [7, 8]. A 20-year follow-up
study showed that 19% of 65,510 Danish cancer patients
were unemployed after a mean duration of 5.2 years [9].
Employment rates of 34,032 Norwegians diagnosed with
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DOI 10.1007/s10926-010-9274-0cancer between 1953 and 2001 showed that 13% of male
cancer survivors and 20% of female cancer survivors were
not employed in 2001 as compared to 8% of male controls
and 14% of female controls [10]. The employment rate of
cancer survivors has most commonly been found to be
associated with age, cancer type and treatment, education,
occupation, and work load [7].
Employees encounter considerable problems when they
resume work after cancer [11, 12]. Apart from the phys-
ical limitations, difﬁculties in managing fatigue and cop-
ing with the stress of having had cancer interfere with
return to work [13]. Furthermore, a non-supportive work
climate and the advice from physicians about work may
postpone return to work [14]. Recently, Verbeek discussed
three opportunities for physicians to help cancer patients
resume their work [15]. The ﬁrst opportunity is including
the skills necessary for return to work in the patient’s
treatment [16]. Secondly, physicians may advise to
accommodate the work environment, for instance by
adjusting work tasks and times and by creating a sup-
portive work environment to facilitate return to work [11].
Finally, occupational rehabilitation should pay attention to
disability cognitions as it has been reported that 20% of
cancer patients mentioned deterioration in work motiva-
tion and career prospects [12].
Few studies have examined the time to return to work
after the diagnosis of cancer. Balak et al. [18] reported that
women with early-stage breast cancer returned to work 4.7
(standard deviation [SD] = 5.4) months after surgery, 3.0
(SD = 3.0) months after ﬁnishing adjuvant radiotherapy,
and 5.5 (SD = 3.2) months after ﬁnishing adjuvant che-
motherapy [18]. The present study investigates the time to
return to work for other cancer types within 2 years after
diagnosis. We were interested in the associations of
demographics (age, gender, socioeconomic status, and
residential region) and occupational factors (occupation,
duration of employment, and company size) with the time
to partial return to work as well as full return to work.
Methods
Study Population and Setting
ArboNed Occupational Health Services contracts Dutch
companies nationwide to provide their employees with
occupational health services. ArboNed collects information
about the employees from the Human Resources depart-
ments of all contracted companies. The ArboNed register
contains the sickness absence data and medical diagnoses
of 1 million employees of whom 22% worked in the
industrial sector and 78% in the service sector. According
to Statistics Netherlands, 23% of the Dutch workforce was
employed in the industrial sector and 73% in the service
sector in 2005 [19].
In The Netherlands, employees report sick to their
employer. The employer records sickness absence and
sends the sick report electronically to the ArboNed register
on the ﬁrst day of sickness absence. Short-term sickness
absence is self-certiﬁed, but sickness absence episodes
exceeding 4 weeks must be medically certiﬁed by an
occupational physician (OP) with diagnoses of the 10th
version of the International Classiﬁcation of Diseases [20].
Sickness Absence Register Data
The ArboNed sickness absence register included 1,091,578
employees in 2004, 1,010,686 employees in 2005, and
1,024,100 employees in 2006 working in more than 30,000
different companies. Employees with sickness absence due
to breast cancer, genital cancer, gastrointestinal cancer,
lung cancer, skin cancer, or blood malignancies were
eligible for this study if they were:
• absent from work due to cancer between 1 January
2004 and 31 December 2006
• in paid permanent employment at the time of diagnosis.
If an employee had more than one episode of sickness
absence due to cancer between January 2004 and Decem-
ber 2006, only the ﬁrst episode was included in the study,
even if the second episode was due to another type of
cancer. Hence, all episodes were independent observations.
The time to full return to work after cancer was compared
to the time to full return to work of 271,834 sickness
absences due to non-malignant disorders, mostly chronic
musculoskeletal disorders (38%), mental disorders (20%),
gastrointestinal disorders (5%), and respiratory disorders
(5%). All employees gave informed consent to the use of
their sickness absence data for scientiﬁc research. Accord-
ing to Dutch law, approval from a medical ethics commit-
tee was not necessary as we analyzed sickness absence
register data and neither consulted medical ﬁles nor
involved the employees personally in the study.
Demographics and Occupational Factors
Age (\35 years, 35–44 years, 45–54 years, and C55 years)
at the time of diagnosis, gender (male, female), socioeco-
nomic status, and residential region were retrieved from the
sickness absence register and included as demographic
independent variables. The socioeconomic status and resi-
dential region were determined by the employees’ zipcodes,
which were recoded into neighbourhood socioeconomic
status estimations according to the guidelines of the Neth-
erlands Institute for Social Research [21]. The residential
regions were divided into a western region (zipcodes
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1231,000–2,999), central region (zipcodes 3,000–3,999), south-
ern region (zipcodes 4,000–5,999), eastern region (zipcodes
6,000–7,999),anda northernregion(zipcodes8,000–9,999).
Occupation, duration of employment (0–5 years, 6–10
years,10–20 years,and[20 years),andcompanysize(\75,
75–500, 501–5,000, and [5,000 staff) were included as
occupational independent variables. Occupations were
categorized using the SBC-1992 (2001 modiﬁed version)
programofStatisticsNetherlands[22],whichisbasedonthe
International Standard Classiﬁcation of Occupations
(ISCO-88) issued by the International Labour Ofﬁce [23].
The SBC-1992 classiﬁcation distinguishes between low
(primaryschoolandjunioroccupationaleducation),medium
(senior occupational education), and high (high school and
university) occupational classes, as well as types of occu-
pations (unskilled workers, technicians, operators, trans-
porters, teachers, care takers, administrators, sales workers,
and managers).
Events: Partial and Full Return to Work
The calendar days between the date of reporting sick and
date of return to work (RTW) were regarded as days of
sickness absence irrespective of the actual work days.
Dutch sickness absence insurance legislation regards epi-
sodes of sickness absence as one episode when they have
less than 28 days of recovery between them, even if the
causes of the episodes differ. We adopted this insurance
time frame of 28 days in our deﬁnitions of RTW. Partial
RTW was deﬁned as working at C50% of the earnings
before sickness absence for at least 28 consecutive days.
Full RTW was deﬁned as working at equal earnings as
before sickness absence for at least 28 consecutive days.
Data were censored if RTW did not occur within 2 years
after diagnosis and if employees left employment
(n = 446) or died (n = 324) within 2 years after diagnosis.
Statistics
Cox proportional hazards models are widely used to ana-
lyse survival data. Although a time-dependence parameter
can be imposed in Cox models, parametric models are
preferred when time itself is an independent variable [24].
Time plays an important role in RTW, as the probability of
resuming work decreases with increasing duration of
sickness absence [25, 26]. Different types of parametric
models can be distinguished, based on the time dependence
of the hazard that is the probability of the event occurring
[27, 28]. The hazard function reﬂects the baseline hazard
for an average individual in the sample at any moment in
time. The generalized gamma (GG) distribution is a three-
parameter hazard function with location parameter (c),
scale parameter (d), and shape parameter (j). The GG
distribution over time (t) is given by the probability density
function:
fGGðtÞ¼
d jj cðctÞ
jd 1 exp  ðctÞ
d
hi
CðjÞ
in which C denotes the gamma function C ¼
R 1
0 xj 1e xdx
[29, 30].
The GG distribution is convenient because it includes
monotonically increasing or decreasing hazard functions,
as well as bathtub-shaped or arc-shaped functions [28–32].
This advantage, however, is neutralized by the difﬁculties
in estimating the GG parameters [31]. Lawless [32] rec-
ommended the Maximum Likelihood Method (MLM) to
select arbitrary values of j and generate the maximum
likelihood estimates of c and d for any given j [32]. The
optimal value of j is determined by comparing the likeli-
hood ratios for alternative values of j. Using the MLM
strategy, we calculated a GG model with j = 10 for the
baseline hazard function (Fig. 1a). In order to check the
statistical ﬁt of this parametric GG model, generalized
residuals were computed [33]. The residuals follow a
straight line in the residual plot if the GG model is
appropriate (Fig. 1b).
Lawless also showed that the GG regression model can
be written as: log(t) = b0 ? b1X1 ? b2X2 ? …… ?
biXi ? e
d [32] in which e is an error term and d determines
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Fig. 1 a The hazard function over time for partial return to work
(dark grey line) and full return to work (light grey line). b Residual
plot showing the ﬁt of the generalized gamma model for partial return
to work (dark grey line) and full return to work (light grey line)
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123the error variance. The GG regression model estimates the
GG regression coefﬁcients (bGG)b 1 to bi.I fab GG is neg-
ative then an increase in the corresponding variable
shortens the expected duration until the occurrence of
RTW, whereas it has the opposite effect when the bGG is
positive [34]. All analyses were performed in Transition
Data Analysis (TDA, version 6.4o), which is the preferred
software for parametric survival models [24, 35], control-
ling for type of cancer, demographics and occupational
variables. Lack of independence or clustering could be
produced by subjects being categorized by a common
factor and this might result in decreased standard errors. To
prevent wrongly rejecting the null hypothesis, the level of
signiﬁcance was set at 1% and signiﬁcance was concluded
for P\0.01.
Results
Between January 2004 and December 2006, 5,234
employees had an episode of sickness absence due to
cancer and were eligible for this study. Breast cancer,
female genital cancer, and gastrointestinal cancer were
most prevalent as is shown in Table 1. 65% of employees
with cancer were C45 years of age, 57% worked in low
occupational classes, and 30% in administration or sales.
The greater part of employees with cancer worked
\10 years in companies employing\500 workers. Follow-
up was incomplete in 770 employees (15%).
The RTW curves per cancer type showed that RTW of
employees after skin cancer and genital cancer was com-
parable to RTW after non-malignant chronic disease
(Fig. 2). For other types of cancer the RTW rates were
lower than for non-malignant chronic disease.
The data of 2,050 employees with cancer were incom-
plete, mainly because of missings in the occupational
independent variables. The employees with incomplete
data did not differ in age category (Chi-square P = 0.46),
gender (Chi-square P = 0.23), or socioeconomic status
(Chi-square P = 0.03) from those with complete data, but
employees living in the western region of The Netherlands
more often had missing data (Chi-square P\0.01). 3,024
employees (58%) with complete data were included in GG
regression analysis.
Partial Return to Work
The time to partial RTW was longer among employees
with breast cancer, gastrointestinal cancer, lung cancer and
blood malignancies, and in men with genital cancer com-
pared to employees with skin cancer (Table 2). The GG
regression coefﬁcients of female genital cancer did not
differ signiﬁcantly from the GG coefﬁcients of skin cancer,
indicating that the partial RTW of women after genital
cancer approximated that of employees with skin cancer,
which was also demonstrated in Fig. 2.
Although young employees (\35 years of age) tended to
resume work earlier (median 124 days after reporting sick)
than employees aged C55 years (median 218 days), the
difference (P = 0.08) was not signiﬁcant at the 1% level.
The time to partial RTW after cancer did not depend on
gender and did not differ across socioeconomic classes or
residential regions (Table 2).
Employeesworkinginhighoccupationalclassesresumed
work earlier than those working inlow occupational classes.
Transporters, administrators and sales workers, and man-
agers started working earlier than unskilled workers, but the
differences in partial RTW after cancer were not signiﬁcant
betweenoccupations (Table 2).Finally,employees working
in companies stafﬁng[5,000 people started working earlier
(median 113 days) than those working in companies stafﬁng
\75 people (median 217 days).
Full Return to Work
The associations of cancer type with full RTW were similar
to those with partial RTW. Employees aged \35 years
fully resumed work earlier (median 181 days) than those
aged C55 years (median 293 days), but, as with partial
RTW, the difference (P = 0.03) was not signiﬁcant at the
1% level. Employees with cancer living in the central
region of The Netherlands had full RTW earlier than those
living in the western provinces. The other demographics
were not associated with the time to full RTW.
In contrast to partial RTW, the occupational class was
not signiﬁcantly associated with the time to full RTW.
Employees working in the public sector were likely to fully
resume work later than those working in the private sector,
but occupations were not signiﬁcantly associated with the
time to full RTW. Employees working 6–10 years for a
company fully resumed work later than those working in a
company for 0–5 years. Employees working in large
companies stafﬁng [5,000 people fully returned to work
earlier (median time 180 days) than those working in small
companies stafﬁng\75 people (median time 313 days).
Discussion
In this study, the time to partial and full RTW after cancer
was assessed using parametric generalized gamma models
for survival data, which account for changes in the hazard
over time. RTW after cancer depended on the type of
cancer and occupational factors. Employees working in
high occupational classes resumed work earlier than those
in low occupational classes, whereas the time to full RTW
434 J Occup Rehabil (2011) 21:431–440
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123did not differ between occupational classes. Employees
working in large companies returned to work earlier than
those working in small companies.
Cancer Type and Return to Work
Generalized gamma survival analysis showed that RTW
occurred later in employees with breast cancer, gastroin-
testinal cancer, and lung cancer as compared to employees
with skin cancer. The duration until both the partial and
full RTW was longest after lung cancer, followed by blood
malignancies and gastrointestinal cancer. These ﬁndings
conﬁrmed Finnish national employment statistics showing
that survivors of lung cancer were least likely to be
employed 3 years after diagnosis, followed by patients
who survived leukemia or non-Hodgkin’s lymphomas [17].
Spelten et al. found that RTW rates were lowest in Dutch
survivors of blood malignancies, but the authors did not
report RTW rates for lung cancer patients [13]. Short et al.
found that American survivors of blood malignancies had
the highest odds of quitting their work, followed by sur-
vivors of central nervous system tumors, head/neck
tumors, and lung cancer [16].
In a recent meta-analysis, De Boer et al. [6] showed that
unemployment was higher in survivors of breast cancer and
gastrointestinal cancer, which is in line with the later RTW
we found in the present study for survivors of these types of
cancer [6]. However, the meta-analysis also showed that
unemployment rates were not higher in survivors of blood
malignancies and male genital cancer, which contrasts the
results of our study. Although RTW after cancer and
unemployment after cancer are related in the sense that no
RTW ultimately results in unemployment, the measures
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Fig. 2 The time to full return to work according to cancer type. The
ﬁgure shows full return to work after breast cancer (n = 1,642),
female genital cancer (n = 878), gastrointestinal cancer (n = 741),
lung cancer (n = 456), male genital cancer (n = 417), skin cancer
(n = 318), blood malignancies (n = 306) and other malignancies
(n = 476); the thin black line reﬂects return to work after chronic
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123Table 2 Survival analysis of return to work stratiﬁed by cancer type using a generalized gamma parametric model
Time to partial return to work Time to full return to work
Median days (99% CI
a)b GG
b (99% CI
a) Median days (99% CI
a)b GG
b (99% CI
a)
Cancer type
Skin 51 (35–67) Reference 75 (45–105) Reference
Breast 271 (246–296) 1.06 (0.76–1.37)** 349 (329–369) 1.08 (0.84–1.33)**
$Genital 79 (68–90) 0.26 (-0.06 to 0.58) 104 (90–118) 0.22 (-0.04 to 0.48)
Gastrointestinal 249 (201–297) 1.35 (1.03–1.66)** 344 (291–397) 1.31 (1.05–1.56)**
Lung 377 (307–447) 1.88 (1.51–2.25)** 484 (351–617) 1.61 (1.31–1.92)**
#Genital 112 (87–137) 0.63 (0.27–0.98)** 164 (116–212) 0.71 (0.43–1.00)**
Blood 299 (236–362) 1.56 (1.17–1.94)** 392 (302–482) 1.50 (1.19–1.81)**
Other 222 (174–270) 1.19 (0.85–1.53)** 297 (219–375) 1.08 (0.81–1.36)**
Demographics
Age
C 55 years 218 (192–244) Reference 293 (260–326) Reference
45–54 years 206 (180–232) -0.07 (-0.24 to 0.10) 288 (256–320) -0.02 (-0.16 to 0.12)
35–44 years 165 (127–203) -0.11 (-0.30 to 0.09) 259 (221–297) -0.07 (-0.24 to 0.09)
\35 years 124 (90–158) -0.17 (-0.42 to 0.08) 181 (127–235) -0.16 (-0.37 to 0.04)
Gender
Men 193 (170–216) Reference 272 (242–302) Reference
Women 200 (177–223) 0.20 (-0.03 to 0.43) 273 (249–297) 0.13 (-0.06 to 0.32)
Socioeconomic status
Low 200 (168–232) Reference 275 (239–311) Reference
Below average 201 (166–236) 0.01 (-0.19 to 0.20) 272 (234–310) 0.02 (-0.13 to 0.18)
Above average 198 (165–231) -0.05 (-0.23 to 0.14) 277 (244–310) -0.01 (-0.16 to 0.14)
High 189 (158–220) -0.04 (-0.24 to 0.15) 270 (229–311) 0.00 (-0.16 to 0.16)
Residential region
West 197 (164 - 230) Reference 293 (252–334) Reference
Central 180 (144–216) -0.12 (-0.32 to 0.07) 257 (206–308) -0.16 (-0.32 to -0.00)**
South 190 (161–219) -0.01 (-0.20 to 0.18) 268 (231–305) -0.11 (-0.26 to 0.04)
East 205 (158–252) -0.00 (-0.20 to 0.20) 257 (217–297) -0.16 (-0.32 to 0.01)
North 232 (196–268) 0.06 (-0.18 to 0.30) 298 (253–343) -0.05 (-0.24 to 0.15)
Occupational factors
Occupational class
Low 199 (176–222) Reference 265 (240–290) Reference
Medium 195 (168 - 222) -0.14 (-0.32 to 0.03) 286 (254–318) 0.03 (-0.11 to 0.17)
High 183 (137–229) -0.31 (-0.57 to -0.04)** 275 (228–322) -0.03 (-0.25 to 0.19)
Occupation
Unskilled 219 (171–267) Reference 287 (220–354) Reference
Public sector
Health care workers 204 (160–248) -0.01 (-0.27 to 0.24) 283 (231–335) -0.07 (-0.27 to 0.14)
Teachers and civil servants 260 (200–320) 0.12 (-0.24 to 0.48) 326 (269–383) -0.01 (-0.31 to 0.28)
Private sector
Technicians 190 (148–232) -0.02 (-0.33 to 0.29) 279 (206–352) -0.08 (-0.34 to 0.17)
Operators 197 (129–265) -0.21 (-0.55 to 0.14) 254 (177–331) -0.15 (-0.43 to 0.13)
Transporters 188 (131–245) -0.06 (-0.38 to 0.26) 247 (213–281) 0.01 (-0.25 to 0.28)
Administrators & salesworkers 177 (148–206) -0.21 (-0.43 to 0.02) 272 (239–305) -0.08 (-0.27 to 0.10)
Managers 154 (90–218) -0.18 (-0.53 to 0.18) 248 (206–290) -0.06 (-0.35 to 0.24)
Other 162 (64–260) -0.24 (-0.83 to 0.36) 273 (73–473) -0.19 (-0.67 to 0.30)
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123differ in time frame and context. RTW often takes places
within the context of sickness absence and disability poli-
cies, whereas unemployment was assessed three to 20 years
after diagnosis in most studies and depends on the social
security policies of a country.
The Association of Demographics with Return to Work
of Cancer Survivors
Age was not signiﬁcantly associated with RTW after can-
cer at the 1% signiﬁcance level, which corroborated the
results of the aforementioned meta-analysis in which it was
reported that the age of cancer survivors was not a prog-
nostic risk factor for future unemployment [6]. Our results
added that there were no gender differences in partial RTW
and full RTW after cancer.
Neither the time to partial RTW nor the time to full
RTW was associated with the socioeconomic status, indi-
cating that people living in poor neighbourhoods did not
resume work later than those living in wealthy neigh-
bourhoods. Earlier studies have reported that a low socio-
economic status was related to a reduced likelihood of
resuming work after cancer [36, 37]. However, a proper
comparison is unfeasible because we used a contextual
proxy to estimate the socioeconomic status instead of a
family [36] or individual [37] measure.
The Association of Occupational Factors with Return
to Work of Cancer Survivors
A review of 18 studies concerning the need for further
research in cancer and work was published in 2004 [38]. In
recent years, there has been increased interest in factors
that may be related to cancer survivors’ disability or
decreased ability to work. Physical workload and heavy
lifting have been associated with higher unemployment
rates [13, 38–43]. Also, employees working in blue collar
occupations were more likely to be unemployed than those
working in white collar occupations [36, 42]. Our results
showed that employees in high occupational classes started
working earlier than employees working in low occupa-
tional classes. This conﬁrms the ﬁnding that cancer survi-
vors with low educational levels were less likely to be
employed than age- and gender-matched healthy referents
[40]. Lower class jobs are more likely to be physically
straining and maybe work tasks and working hours can be
more easily adjusted in high class jobs.
Taskila and colleagues reported that cancer survivors
working in agricultural work, forestry and ﬁshery, trans-
port and communication, and manufacturing had an
18–20% lower probability of being employed 3 years after
diagnosis than age-matched employees without cancer
[41]. The median time to full RTW in our study was
shorter, though not signiﬁcantly, among transporters
(247 days) and operators (254 days) compared to unskil-
led workers (287 days). It may be possible that trans-
porters and operators resume work initially, but quit their
work on a later moment, for instance because of the
physical workload or because they can not keep pace with
colleagues [39, 42]. Alternatively, a worker may continue
working in the same occupation, but under different
working conditions. In this regard, it should be acknowl-
edged that not only the content of occupations deﬁned in
this study may differ from the occupations classiﬁed by
Taskila et al. [41], but also the working conditions. For
example, employees working in Dutch manufacturing
Table 2 continued
Time to partial return to work Time to full return to work
Median days (99% CI
a)b GG
b (99% CI
a) Median days (99% CI
a)b GG
b (99% CI
a)
Duration of employment (years)
0–5 160 (130–190) Reference 221 (183–259) Reference
6–10 214 (186–242) 0.11 (-0.06 to 0.29) 294 (263–325) 0.18 (0.04–0.33)**
11–20 210 (171–249) 0.10 (-0.09 to 0.30) 292 (258–326) 0.12 (-0.04 to 0.28)
[20 197 (167–227) 0.00 (-0.20 to 0.21) 259 (226–292) 0.03 (-0.14 to 0.20)
Company size
\75 217 (173–261) Reference 313 (273–353) Reference
75–500 203 (174–232) -0.10 (-0.28 to 0.08) 275 (243–307) -0.11 (-0.26 to 0.04)
500–5,000 197 (172–222) -0.13 (-0.31 to 0.05) 272 (240–304) -0.10 (-0.25 to 0.05)
[5,000 113 (74–152) -0.56 (-0.82 to -0.29)** 180 (127–233) -0.54 (-0.76 to -0.33)**
** P\0.01
a Conﬁdence interval
b Generalized gamma regression coefﬁcient; a negative coefﬁcient indicates a shorter duration until return to work and a positive coefﬁcient a
longer duration
438 J Occup Rehabil (2011) 21:431–440
123industry were mostly machine-operators and therefore less
exposed to physical workloads.
Our results showed that RTW of cancer survivors was
associated with the company size rather than occupation.
Cancer survivors working in large companies started
working earlier and had full RTW earlier than those
working in small companies. We assume this is due to the
fact that it is easier in large companies to accommodate
work tasks and working hours to the work ability and
vulnerability of cancer survivors. Furthermore, cancer
survivors who were employed for 6–10 years fully returned
to work later than those who were employed B5 years.
Cancer survivors who are employed B5 years may be
younger than those employed for many years, and young
cancer survivors had earlier full RTW than those aged
C55 years. Alternatively, employees working for a com-
pany B5 years may be more anxious to lose their job when
sickness absence lasts too long.
Strengths and Limitations of the Study
The strength of our study is that we retrieved sickness
absence register data of approximately 1 million workers,
who were representative of the Dutch workforce. Sickness
absence legislation and policies in The Netherlands did not
change between January 2004 and December 2008. The
diagnoses on the sickness absence certiﬁcates were not
tested. However, there is hardly any doubt that occupa-
tional physicians write cancer as diagnosis on the sickness
certiﬁcates of employees who do not have cancer. The
sickness absence certiﬁcates included only one medical
diagnosis. Therefore, we had no knowledge about co-
morbidity, such as fatigue, distress and depressive symp-
toms that are frequently found in cancer survivors [8, 11]
and interfere with RTW.
A disadvantage of using sickness absence register data is
that these data are recorded for other than research pur-
poses. Hence, we had no control over which data were
recorded and how data were registered. The interpretation
of results was hampered by the fact that it was not possible
to ‘dig deeper’ into the data. Moreover, we had no access to
the medical ﬁles of the employees, so information on the
cancer stage (local, regional, or metastatic), type of treat-
ment, and side effects or complications of treatment was
not available. It has been recognised that the employment
of cancer survivors depends strongly on the type, extent,
and treatment of cancer [11, 16, 44]. Also, information
about impairments in physical and mental work ability and
adjustments in the working conditions (e.g. ergonomic
work improvements, accommodated work tasks, reduced
working hours, placement in another job) was not avail-
able while these factors obviously facilitate RTW after
cancer.
We conclude that the time to partial and full RTW after
cancer depended on the type of cancer and occupational
factors. Occupational factors are modiﬁable, although the
accommodation of work tasks or working hours will be
more difﬁcult in lower class occupations and in small
companies. It will be interesting to investigate the work
role functioning of employees who resumed work after
cancer in order to monitor how cancer survivors manage
residual symptoms, physical limitations, and changed
psychological cognitions. Such research will provide keys
and tools for a sustainable working life of cancer survivors.
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